Theracurmin (Highly Bioavailable Curcumin) Prevents High Fat Diet-Induced Hepatic Steatosis Development in Mice |
Yang, Jin Won
(College of Pharmacy, Woosuk University)
Yeo, Hee Kyung (HANDOK Inc.) Yun, Jee Hye (HANDOK Inc.) Lee, Jung Un (ChemOn Inc.) |
1 | Browning, J.D. and Horton, J.D. (2004) Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest., 114, 147-152. DOI |
2 | Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M. and Sanyal, A.J. (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat. Med., 24, 908-922. DOI |
3 | Birkenfeld, A.L. and Shulman, G.I. (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology, 59, 713-723. DOI |
4 | Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. and Tiribelli, C. (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med., 14, 72-81. DOI |
5 | Kotronen, A. and Yki-Jarvinen, H. (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol., 28, 27-38. DOI |
6 | Rinella, M.E. (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA, 313, 2263-2273. DOI |
7 | Sunagawa, Y., Hirano, S., Katanasaka, Y., Miyazaki, Y., Funamoto, M., Okamura, N., Hojo, Y., Suzuki, H., Doi, O., Yokoji, T., Morimoto, E., Takahashi, T., Ozawa, H., Imaizumi, A., Ueno, M., Kakeya, H., Shimatsu, A., Wada, H., Hasegawa, K. and Morimoto, T. (2015) Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study. J. Nutr. Sci. Vitaminol., 61, 37-44. DOI |
8 | Maria, M., Eleni, P., George, V., Eftychia, T. and Constantinos, G. (2018) Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother. Res., 32, 957-975. DOI |
9 | Ohno, M., Nishida, A., Sugitani, Y., Nishino, K., Inatomi, O., Sugimoto, M., Kawahara, M. and Andoh, A. (2017) Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS ONE, 12, e0185999. DOI |
10 | Farzaei, M.H., Zobeiri, M., Parvizi, F., El-Senduny, F.F., Marmouzi, I., Coy-Barrera, E., Naseri, R., Nabavi, S.M., Rahimi, R. and Abdollahi, M. (2018) Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients, 10, E855. DOI |
11 | Imaizumi, A. (2015) Highly bioavailable curcumin (Theracurmin): its development and clinical application. Pharma-Nutrition, 3, 123-130. DOI |
12 | Ding, L., Li, J., Song, B., Xiao, X., Zhang, B., Qi, M., Huang, W., Yang, L. and Wang, Z. (2016) Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol. Appl. Pharmacol., 304, 99-109. DOI |
13 | Cichoz-Lach, H. and Michalak, A. (2014) Oxidative stress as a crucial factor in liver diseases. World J. Gastroenterol., 20, 8082-8091. DOI |
14 | Shao, W., Yu, Z., Chiang, Y., Yang, Y., Chai, T., Foltz, W., Lu, H., Fantus, I.G. and Jin, T. (2012) Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE, 7, e28784. DOI |
15 | Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A., Fukuda, H., Hashimoto, T., Wada, H., Katanasaka, Y., Kakeya, H., Fujita, M., Hasegawa, K. and Morimoto, T. (2011) Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull., 34, 660-665. DOI |
16 | Cuomo, J., Appendino, G., Dern, A.S., Schneider, E., McKinnon, T.P., Brown, M.J., Togni, S. and Dixon, B.M. (2011) Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J. Nat. Prod., 74, 664-669. DOI |
17 | Gota, V.S., Maru, G.B., Soni, T.G., Gandhi, T.R., Kochar, N. and Agarwal, M.G. (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J. Agric. Food Chem., 58, 2095-2099. DOI |
18 | Sunagawa, Y., Wada, H., Suzuki, H., Sasaki, H., Imaizumi, A., Fukuda, H., Hashimoto, T., Katanasaka, Y., Shimatsu, A., Kimura, T., Kakeya, H., Fujita, M., Hasegawa, K. and Morimoto, T. (2012) A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats. Biol. Pharm. Bull., 35, 139-144. DOI |
19 | Liu, Y., Cheng, F., Luo, Y., Zhan, Z., Hu, P., Ren, H., Tang, H. and Peng, M. (2017) PEGylated curcumin derivative attenuates hepatic steatosis via CREB/PPAR-gamma/CD36 pathway. BioMed Res. Int., 2017, 8234507. |
20 | Oner-Iyidogan, Y., Kocak, H., Seyidhanoglu, M., Gurdol, F., Gulcubuk, A., Yildirim, F., Cevik, A. and Uysal, M. (2013) Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. J. Physiol. Biochem., 69, 677-686. DOI |
21 | Greenberg, A.S., Coleman, R.A., Kraemer, F.B., McManaman, J.L., Obin, M.S., Puri, V., Yan, Q.W., Miyoshi, H. and Mashek, D.G. (2011) The role of lipid droplets in metabolic disease in rodents and humans. J. Clin. Invest., 121, 2102-2110. DOI |
22 | Ioannou, G.N. (2016) The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol. Metab., 27, 84-95. DOI |
23 | Rolo, A.P., Teodoro, J.S. and Palmeira, C.M. (2012) Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med., 52, 59-69. DOI |
24 | Walenbergh, S.M. and Shiri-Sverdlov, R. (2015) Cholesterol is a significant risk factor for non-alcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol., 9, 1343-1346. DOI |
25 | Shimano, H. and Sato, R. (2017) SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat. Rev. Endocrinol., 13, 710-730. DOI |
26 | Yang, J.W., Kim, H.S., Im, J.H., Kim, J.W., Jun, D.W., Lim, S.C., Lee, K., Choi, J.M., Kim, S.K. and Kang, K.W. (2016) GPR119: a promising target for nonalcoholic fatty liver disease. FASEB J., 30, 324-335. DOI |
27 | Moore, K.J., Rayner, K.J., Suarez, Y. and Fernandez-Hernando, C. (2011) The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu. Rev. Nutr., 31, 49-63. DOI |
28 | Tariq, Z., Green, C.J. and Hodson, L. (2014) Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)? Liver Int., 34, e180-e190. DOI |
29 | Spahis, S., Delvin, E., Borys, J.M. and Levy, E. (2017) oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid. Redox Signal., 26, 519-541. DOI |
30 | Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., Lengyel, G., Mann, G.E., Pamplona, R., Poli, G., Portero-Otin, M., Riahi, Y., Salvayre, R., Sasson, S., Serrano, J., Shamni, O., Siems, W., Siow, R.C.M., Wiswedel, I., Zarkovic, K. and Zarkovic, N. (2010) Pathological aspects of lipid peroxidation. Free Radic. Res., 44, 1125-1171. DOI |
31 | He, H.-J., Wang, G.-Y., Gao, Y., Ling, W.-H., Yu, Z.-W. and Jin, T.-R. (2012) Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J. Diabetes, 3, 94. DOI |
32 | Wei, Q.Y., Chen, W.F., Zhou, B., Yang, L. and Liu, Z.L. (2006) Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim. Biophys. Acta, 1760, 70-77. DOI |
33 | Scapagnini, G., Vasto, S., Abraham, N.G., Caruso, C., Zella, D. and Fabio, G. (2011) Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol. Neurobiol., 44, 192-201. DOI |
34 | Yang, C., Zhang, X., Fan, H. and Liu, Y. (2009) Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res., 1282, 133-141. DOI |